Systematic Review on the Effectiveness of Anti-embolism Stockings; A Need to Re-evaluate the Evidence

Description

In this presentation, Mahmoud Awadallah, an orthopedic registrar from Peterborough, discusses the effectiveness of Anti-Embolism stockings in clinical practice, particularly in preventing deep vein thrombosis (DVT) and pulmonary embolism (PE). He highlights a systematic review of 25 randomized controlled trials involving over 8,279 patients, comparing rates of DVT in patients using stockings versus those who did not. The results showed a DVT prevalence of 7.4% in the stocking group compared to 11.9% in the non-stock group, suggesting stockings might be beneficial. However, Awadallah cautions that newer studies indicate a lack of statistically significant benefits, raising questions about their current efficacy. He urges re-evaluation of their use, particularly in the context of modern early mobility protocols and new pharmacological prophylaxis options. The cost to the NHS is also addressed, estimating an expenditure of around £20 million per year on stockings, prompting considerations of their cost-effectiveness. The discussion concludes with an emphasis on the need for further research to better establish efficacy and guide clinical guidelines.

DOI: 10.1302/3114-221383

Specialties

Conferences